Skip to main content
. 2016 Nov 21;8(2):298–304. doi: 10.1002/jcsm.12161

Table 1.

Patients demographics and response to chemoimmunotherapy divided by skeletal muscle density (SMD) and low (≤25 kg/m2) or high (>25 kg/m2) body mass index (BMI)

Demographic All (224) Low SMD (116) High SMD (108) Low vs. High SMD p‐value
Low BMI (43) High BMI (73) Low BMI (38) High BMI (70)
Age at diagnosis, median (years) 62 (21–88) 65 69 49 56 <0.0001
Sex, # 0.02
Male 125 (56%) 19 (44%) 34 (47%) 25 (66%) 47 (59%)
Female 99 (44%) 24 (56%) 39 (53%) 13 (34%) 23 (41%)
Body weight, median (kg) 75.7 61.7 83.3 61.8 78.8 <0.0001
Body mass index, median (kg/m2) 26.8 22.5 30.1 22.2 28.0 <0.0001
Stage, # 0.24
I 50 (22%) 8 (19%) 13 (18%) 6 (16%) 23 (33%)
II 44 (20%) 5 (12%) 13 (18%) 12 (32%) 14 (20%)
III 27 (12%) 4 (9%) 13 (18%) 3 (8%) 7 (10%)
IV 103 (46%) 26 (60%) 34 (47%) 17 (45%) 26 (33%)
R‐IPI, # 0.0001
0 18 (8%) 0 2 (3%) 8 (21%) 8 (11%)
1 44 (20%) 5 (12%) 12 (16%) 9 (24%) 18 (26%)
2 48 (21%) 6 (14%) 14 (19%) 5 (13%) 23 (33%)
3 58 (26%) 18 (42%) 21 (29%) 7 (18%) 12 (17%)
4 40 (18%) 8 (19%) 15 (21%) 9 (24%) 8 (11%)
5 16 (7%) 6 (14%) 9 (12%) 0 1 (1%)
Chemoimmunotherapy cycles received, median 6 6 6 6 6
Best response to chemoimmunotherapy, # 0.04
Complete response 168 (75%) 30 (70%) 46 (63%) 31 (82%) 61 (87%) 0.0007
Partial response 41 (18%) 9 (21%) 21 (29%) 7 (18%) 4 (6%)
Stable disease 2 (0.1%) 1 (2%) 0 0 1 (1%)
Progressive disease 13 (6%) 3 (7%) 6 (8%) 0 4 (6%)
Required at least 1 cycle delayed, # 90 (40%) 17 (40%) 30 (41%) 18 (47%) 25 (36%) 0.78
CT measures
Median skeletal muscle area (cm2) 130.7 109.1 126.0 127.6 157.6 <0.0001
Median skeletal muscle index (SMI, cm2/m2) 47.7 40.4 46.5 45.0 54.3 <0.0001
SMD (HU) 34.1 32.9 25.0 45.5 38.9 <0.0001